Cargando…

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy

BACKGROUND: The magnitude and rapidity of the tumor response to androgen deprivation is known to predict the durability of the therapy. We have investigated the predictive value of categorizing patients by the half-life of PSA under neoadjuvant androgen deprivation therapy in patients with biochemic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Yong Jin, Jang, Won Sik, Kwon, Jong Kyou, Yoon, Cheol Yong, Lee, Joo Yong, Ham, Won Sik, Choi, Young Deuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701379/ https://www.ncbi.nlm.nih.gov/pubmed/29169347 http://dx.doi.org/10.1186/s12885-017-3775-6

Ejemplares similares

The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer
por: Jang, Won Sik, et al.
Publicado: (2016)

Impact of lymphovascular invasion on lymph node metastasis for patients undergoing radical prostatectomy with negative resection margin
por: Kang, Yong Jin, et al.
Publicado: (2017)

Predictors of adverse pathologic features after radical prostatectomy in low-risk prostate cancer
por: Park, Jae Won, et al.
Publicado: (2018)

Effect of Preoperative Risk Group Stratification on Oncologic Outcomes of Patients with Adverse Pathologic Findings at Radical Prostatectomy
por: Jang, Won Sik, et al.
Publicado: (2016)

Comparison of Pathological and Biochemical Outcomes after Radical Prostatectomy in Korean Patients with Serum PSA Ranges
por: Lee, Hye Won, et al.
Publicado: (2015)

Impact of Early Salvage Androgen Deprivation Therapy in Localized Prostate Cancer after Radical Prostatectomy: A Propensity Score Matched Analysis
por: Park, Jae Won, et al.
Publicado: (2018)

Current Status of Radical Prostatectomy for High-Risk Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2014)

Clinical significance of multiparametric MRI and PSA density as predictors of residual tumor (pT0) following radical prostatectomy for T1a-T1b (incidental) prostate cancer
por: Chung, Doo Yong, et al.
Publicado: (2018)

Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI
por: Chung, Doo Yong, et al.
Publicado: (2018)

Management of postoperative ileus after robot-assisted laparoscopic prostatectomy
por: Park, Jee Soo, et al.
Publicado: (2018)

The natural history of a delayed detectable PSA after radical prostatectomy
por: Szymaniak, Julie A., et al.
Publicado: (2023)

Outcomes of pathologically localized high-grade prostate cancer treated with radical prostatectomy
por: Heo, Ji Eun, et al.
Publicado: (2019)

The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy
por: Cho, Sung Yong, et al.
Publicado: (2016)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients
por: Park, Jae Won, et al.
Publicado: (2018)

PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011)

Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy
por: Asha, Wafa, et al.
Publicado: (2023)

Comparison of High, Intermediate, and Low Frequency Shock Wave Lithotripsy for Urinary Tract Stone Disease: Systematic Review and Network Meta-Analysis
por: Kang, Dong Hyuk, et al.
Publicado: (2016)

Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy
por: Matsumoto, Kazuhiro, et al.
Publicado: (2021)

Comparison of Biochemical Recurrence After Robot-assisted Laparoscopic Radical Prostatectomy with Volatile and Total Intravenous Anesthesia
por: Kim, Na Young, et al.
Publicado: (2020)

Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
por: Kang, Ho Won, et al.
Publicado: (2016)

The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2017)

Predictive Factors and Oncologic Outcome of Downgrade to Pathologic Gleason Score 6–7 after Radical Prostatectomy in Patients with Biopsy Gleason Score 8–10
por: Chung, Doo Yong, et al.
Publicado: (2019)

Effect of prostate gland weight on the surgical and oncological outcomes of extraperitoneal robot-assisted radical prostatectomy
por: Kim, Min Seok, et al.
Publicado: (2019)

Association of Anterior and Lateral Extraprostatic Extensions with Base-Positive Resection Margins in Prostate Cancer
por: Kang, Yong Jin, et al.
Publicado: (2016)

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
por: Quero, Laurent, et al.
Publicado: (2008)

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
por: Doherty, A P, et al.
Publicado: (2000)

Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy
por: Naiki, Taku, et al.
Publicado: (2012)

A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging
por: Lee, Joo Yong, et al.
Publicado: (2015)

Analysis of risk factors for positive surgical margin after laparoscopic radical prostatectomy with and without neoadjuvant hormonal therapy
por: Wang, Fangming, et al.
Publicado: (2023)

Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy
por: Grasso, Marco, et al.
Publicado: (2004)

Optimal Skin-to-Stone Distance Is a Positive Predictor for Successful Outcomes in Upper Ureter Calculi following Extracorporeal Shock Wave Lithotripsy: A Bayesian Model Averaging Approach
por: Cho, Kang Su, et al.
Publicado: (2015)

(68)Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
por: von Eyben, Finn Edler, et al.
Publicado: (2021)

The Relationships between Survivals and Early Salvage Androgen Deprivation Therapy for Non-Organ Confined Prostate Cancer after Radical Prostatectomy
por: Park, Jae Won, et al.
Publicado: (2020)

Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?
por: Lee, Hye Won, et al.
Publicado: (2015)

The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer
por: Joung, Jae Young, et al.
Publicado: (2015)

Impact of Prostate Size on Pathologic Outcomes and Prognosis after Radical Prostatectomy
por: Min, Sun Ho, et al.
Publicado: (2012)

Urethral realignment with maximal urethral length and bladder neck preservation in robot-assisted radical prostatectomy: Urinary continence recovery
por: Heo, Ji Eun, et al.
Publicado: (2020)

Muscle Characteristics Obtained Using Computed Tomography as Prognosticators in Patients with Castration-Resistant Prostate Cancer
por: Lee, Jongsoo, et al.
Publicado: (2020)

Ureteral stenting can be a negative predictor for successful outcome following shock wave lithotripsy in patients with ureteral stones
por: Kang, Dong Hyuk, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u0pft6n3b8099u1m1cilbtsf2l